Related Experiment Video
Updated: Feb 5, 2026

Isolation of Peritoneum-derived Mast Cells and Their Functional Characterization with Ca2+-imaging and Degranulation Assays
Published on: July 4, 2018
[EFFECT OF MAST CELL DEGRANULATION BLOCKADE ON THE INFLAMMATION OUTCOME IN THE MODEL OF OBSTRUCTIVE LUNG PATHOLOGY]
Abstract:
Effect of mast cell degranulation blockade on the inflammatory response and character of the lung tissue structure-functional changes were evaluated in the chronic obstructive pulmonary disease model produced in rats by 60-day intermittent exposure to nitrogen dioxide. The membrane stabilizer sodium cromoglicate was used to blockade of mast cell degranulation. Lung tissue sections were stained with toluidine blue to identify mast cells. Bronchoalveolar lavage fluid (BALF) cytogram was determined. The levels of mast cell tryptase and chymase, proinflammatory cytokine TNF-α, surfactant protein B were measured in BALF. Suppression of mast cell degranulation prevented the release of proteases in the bronchoalveolar space and reduced activity of the inflammatory process. The influx of inflammatory cells and TNF-α concentration decreased. There was no interstitial inflammatory infiltration. Bronchoalveolar epithelium structure was recovered that is the basis of its functional usefulness. The results confirm the active involvement of mast cells in the development of the inflammatory process in obstructive pulmonary diseases and allow us to consider them as a possible therapeutic target.
Insights
Blocking mast cell degranulation in a rat model of chronic obstructive pulmonary disease reduced inflammation and improved lung tissue structure. This suggests mast cells are a viable therapeutic target for obstructive lung diseases.
Area of Science:
- Pulmonary Medicine
- Immunology
- Pathology
Background:
- Chronic obstructive pulmonary disease (COPD) involves significant lung inflammation and structural damage.
- Mast cells play a recognized role in mediating inflammatory responses in the airways.
Purpose of the Study:
- To investigate the effect of blocking mast cell degranulation on COPD-induced lung inflammation and tissue changes.
- To evaluate mast cells as a potential therapeutic target in COPD.
Main Methods:
- A rat model of COPD was established using chronic nitrogen dioxide exposure.
- Sodium cromoglicate was administered to block mast cell degranulation.
- Analysis included lung tissue staining, bronchoalveolar lavage fluid (BALF) analysis, and measurement of inflammatory markers (proteases, TNF-α).
Main Results:
- Mast cell degranulation blockade reduced protease release and inflammatory cell influx into the lungs.
- Tumor necrosis factor-alpha (TNF-α) levels decreased, and interstitial inflammation was absent.
- Bronchoalveolar epithelium structure and function were restored.
Conclusions:
- Mast cells are actively involved in the inflammatory processes of COPD.
- Inhibiting mast cell degranulation can ameliorate lung inflammation and structural damage in COPD.
- Targeting mast cells represents a promising therapeutic strategy for obstructive pulmonary diseases.
More Related Videos
Related Concept Videos
Inflammation
Neuromuscular Junction And Blockade
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
Predicting Reaction Outcomes
Lung Capacity
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

